We never stop
SimCardioTest is an international project funded by the European Commission (EU H2020) that brings together 10 organizations – we are one of them – from 6 European countries and the United States. Its aim is to provide new insights into designing predictive tools for cardiac pathologies and to accelerate the uptake of computer simulations for testing medicines and medical devices.
Brainteaser is a data science project that seeks to exploit the value of big data, including those related to health, lifestyle habits, and environment, to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. By taking advantage of cost-efficient sensors and apps, Brainteaser will integrate large, clinical datasets that host both patient-generated and environmental data. Our role in this project also includes exploitation, or taking scientific research to the industry.
In Silico World
In Silico World is a project funded by the European Union that involves 14 partner institutions, including us. The aim is to accelerate the uptake of modelling and simulation technologies for the development and regulatory assessment of medicines and medical devices. The project will develop 11 solutions leveraging state-of-the-art computational technologies to treat osteoporosis, tuberculosis, multiple sclerosis, coronary stenosis, cerebral aneurysms, mammary carcinoma, and covid-19 infection.
Training network to advance integrated computational simulations in translational medicine, applied to intervertebral disc degeneration. The Disc4All training network utilises intervertebral disc degeneration (LDD) leading to low back pain (LBP) as a relevant application for the integration of data and computational simulations in translational medicine, to enable rational interpretations of the complexity of the interactions that eventually lead to symptoms.
METASTRA, is set to transform the way clinicians assess fracture risk in cancer patients with vertebral metastases. The ambitious project funded by the EU’s Horizon Europe “Tools and technologies for a healthy society” Call promises to provide personalised treatment recommendations based on robust computational models and improved patient stratification techniques. Coordinated by the University of Bologna, METASTRA brings together 15 partners from different European Member States, receiving a total funding of 6.7 Mil EUR over the next five years.